Aspire Biopharma Announces $21 Million Private Placement by Select Investors, Strengthening Balance Sheet, Capital Position, and Fortifying Shareholder Equity to …

ESTERO, FLORIDA / ACCESS Newswire / February 11, 2026 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the ...

Aspire Biopharma Files Provisional Patent Application for a Fast-Acting Sublingual Powder Formulation of Ondansetron (Generic Zofran(R))

New sublingual delivery system designed to provide more rapid relief from nausea caused by cancer medicinesOndansetron, ...
Visual Studio Magazine

Building Real-World Web Apps with ASP.NET Core Razor Pages

Microsoft MVP Philip Japikse discusses how ASP.NET Core Razor Pages in .NET 10 provides a streamlined, page-centric ...